Caster Semenya Goes To Human Rights Court To Protest Her Testosterone Case

KEY POINTS

  • Olympic 800 meter champion Caster Semenya is set to appear before the European Court of Human Rights to appeal against the verdict that restricted testosterone levels in female athletics.
  • The veteran athlete from South Africa still hopes to defend her Olympic title in Tokyo this year despite losing an appeal to Switzerland’s Federal Supreme Court in September.
  • However, her lawyers felt that the ruling was unfair, arguing that Switzerland failed in its obligation to safeguard against the violation of her basic human rights.

- Advertisement -

Olympic 800 meter champion Caster Semenya is set to appear before the European Court of Human Rights to appeal against the verdict that restricted testosterone levels in female athletics.

Caster Semenya has not been able to take part in her races without taking drugs that reduces the testosterone levels after the world athletics governing body changed the rule in 2019.

Recommended Articles :

Recommended Articles :

The veteran athlete from South Africa still hopes to defend her Olympic title in Tokyo this year despite losing an appeal to Switzerland’s Federal Supreme Court in September.

However, her lawyers felt that the ruling was unfair, arguing that Switzerland failed in its obligation to safeguard against the violation of her basic human rights.

“All we ask is to be allowed to run free, for once and for all, as the strong and fearless women we are and have always been,” she stated.

READ MORE:

The athletic governing body came up with a rule that those athletes with differences of sexual development (DSD) participating in the 400m had to take medication in a bid to compete in track events, failure to which they should change to another race.

RELATED STORY: Nigerian Housewife Gives Birth To Six Babies Years After She Was Blessed With Twins

- Advertisement -
- Advertisement -

Stay Connected

16,985FansLike
2,458FollowersFollow
61,453SubscribersSubscribe

Must Read

- Advertisement -

Related News

- Advertisement -